Market Overview

Morgan Stanley Sees Positive Operating Leverage For Invesco Ltd.

Share:
Related IVZ
Invesco: Poised To Outperform
Invesco And The Rise Of Smart Beta
Why Fight Severe Headwinds? (Seeking Alpha)

In a report published Wednesday, Morgan Stanley analyst Betsy L. Graseck reiterated an Equal-Weight rating and $39.00 price target on Invesco Ltd. (NYSE: IVZ).

In the report, Morgan Stanley noted, “While we view IVZ as a global, diversified platform that is likely to generate organic growth above most peers, we remain Equal-weight and view consistently strong positive operating leverage as the most significant positive catalyst going fwd.

"Our forecast calls for stronger margin expansion & EPS growth than most peers, but we remain Equal-weight & believe investors will price IVZ at a discount until it consistently shows these combined factors. We estimate ~$26B outflows through YE2014 related to recent PM departure at Perpetual, although less could signal upside vs our estimates.”

Invesco Ltd. closed on Tuesday at $37.97.

Latest Ratings for IVZ

DateFirmActionFromTo
Sep 2016Deutsche BankMaintainsBuy
Aug 2016BarclaysMaintainsOverweight
Aug 2016Deutsche BankMaintainsBuy

View More Analyst Ratings for IVZ
View the Latest Analyst Ratings

Posted-In: Betsy L. Graseck Morgan StanleyAnalyst Color Reiteration Analyst Ratings

 

Related Articles (IVZ)

View Comments and Join the Discussion!